The Federal Trade Commission and four states sued the World Professional Association for Transgender Health on Wednesday, in the latest push by Donald Trump’s administration and others to limit gender-affirming care for transgender minors.

The suit alleges the group, known widely as WPath, made deceptive claims about gender-affirming care for minors and that its members profited off the claims. Alaska, Iowa, Nebraska and Texas filed along with the FTC.

“Parents have a right to make informed decisions about their children’s health,” FTC chair Andrew Ferguson said on X. “The FTC will not allow parents and children to be deceived by medical organizations and providers who are prioritizing profit over children’s health and safety.”

In a statement, WPath said that its guidelines call for care that is tailored to individual patients, rather than a “one size fits all” approach.

The suit comes following an investigation by the agency into WPath. The group sued to block the investigation, alleging the agency was violating its first amendment rights. A federal judge in May ruled in favor of WPath to temporarily block the investigation from continuing.

The FTC also launched investigations into the American Academy of Pediatrics and the Endocrine Society over their guidelines on gender-affirming care. Both of those groups also sued.

WPATH has established widely-accepted medical standards for gender-affirming care for more than 50 years, the organization’s website notes, based on “established scientific standards, expert consensus and patient-centered values.”

The group noted in a statement that a federal court had already ruled against the FTC over this effort when it blocked the investigation.

“WPATH is in a strong position to prove that the FTC is acting out of pure retaliation as part of the federal government’s relentless and targeted campaign to undermine gender-affirming care by attacking the First Amendment rights and the independence of professional medical organizations,” the statement said. “We expect the same result when we oppose this latest attack on WPATH and its mission to promote evidence-informed care and guidance for doctors and their patients.”